[返回网际谈兵首页]·[所有跟贴]·[ 回复本贴 ]·[版主管理]·[分区新闻]·[繁體閱讀]
麻生:木有 kill switch ? US digital pill to track patients
送交者: 千里迢迢望春风[♂御史大夫★★★☆♂] 于 2017-11-14 12:29 已读 328 次  
US regulators approve first digital pill to track patients

WASHINGTON (AP) — U.S. regulators have approved the first drug with a sensor that alerts doctors when the medication has been taken, offering a new way of monitoring patients but also raising privacy concerns.



The digital pill approved Monday combines two existing products: the former blockbuster psychiatric medication Abilify — long used to treat schizophrenia and bipolar disorder — with a sensor tracking system first approved in 2012.

The technology is intended to help prevent dangerous emergencies that can occur when patients skip their medication, such as manic episodes experienced by those suffering from bipolar disorder.

But developers Otsuka Pharmaceutical Co. and Proteus Digital Health are likely to face hurdles. The pill has not yet been shown to actually improve patients’ medication compliance, a feature insurers are likely to insist on before paying for the pill. Additionally, patients must be willing to allow their doctors and caregivers to access the digital information.

These privacy issues are likely to crop up more often as drugmakers and medical device companies combine their products with technologies developed by Silicon Valley.

The new pill, Abilify MyCite, is embedded with a digital sensor that is activated by stomach fluids, sending a signal to a patch worn by the patient and notifying a digital smartphone app that the medication has been taken.

The FDA stressed however that there are limitations to monitoring patients.

“Abilify MyCite should not be used to track drug ingestion in ‘real-time’ or during an emergency,” the statement said, “because detection may be delayed or may not occur.”

Patients can track their dosage on their smartphone and allow their doctors, family or caregivers to access the information through a website.

In a statement issued last May at the time the FDA accepted submission of the product for review, the companies said “with the patient’s consent, this information could be shared with their healthcare professional team and selected family and friends, with the goal of allowing physicians to be more informed in making treatment decisions that are specific to the patient’s needs.”

While it’s the first time the FDA has approved such a pill, various specialty pharmacies and hospitals in the U.S. have previously “packaged” various drugs and sensors. But the federal endorsement increases the likelihood that insurers will eventually pay for the technology.

Drugmakers frequently reformulate their drugs to extend their patent life and to justify raising prices. For instance, Otsuka already sells a long-acting injectable version of Abilify intended to last for one month. The patent on the original Abilify pill expired in 2015.

The Japanese drugmaker has not said how it will price the digital pill. Proteus Digital Health, based in Redwood City California, makes the sensor.
喜欢千里迢迢望春风朋友的这个贴子的话,[请点这里投票,“赞”助支持!]
[举报反馈]·[ID前期主贴发言]·[返回网际谈兵首页]·[所有跟贴]·[-->>回复本贴]· [-- 登录后分享可获积分 --] ·[返回前页]
贴子内容是网友自行贴上分享,如果您认为其中内容违规或者侵犯了您的权益,请与我们联系,我们核实后会第一时间删除。

所有跟贴:


    加跟贴(积极回贴支持发贴的朋友,才能欣赏到更多精品好贴!)

    用户名:密码:[--注册ID--]

    标 题:

    [所见即所得|预览模式]  [旧版发帖帮助]  [所见即所得发帖帮助]

    粗体 斜体 下划线 居中 插入图片插入图片 插入Flash插入Flash动画 插入音乐插入音乐  插入视频


     发布前预览  图片上传 Youtube代码生成器

    楼主前期本版热贴推荐:

    >>>>查看更多楼主社区动态...






    [ 留园条例 ] [ 广告服务 ] [ 联系我们 ] [ 个人帐户 ] [ 版主申请 ] [ Contact us ]